CD7 and lymphoma: IHC studies (Table 2) showed the lymphoma cells to be positive for CD3 (8/8, 100%), CD4 (7/8, 87.5%), CD7 (2/3, 66%), and CD30 (20/21, 95%, median expression: 80%).